Clinical Trial Update: Efficacy and Safety Study of BMS-986142 in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of BMS-986142 in adults with moderate to severe rheumatoid arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BMS-986142

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2019-05-28